Scientific Program 2019-11-17


08:30

SESSION 7 – MICRO-TRANSPLANT

  • 08.30 Micro-transplant: Beijing update H. AI, Beijing, China
  • 09.00 Importance of donor source for microtransplant J. Hu, Shanghai, China
09:30

SPONSORED LECTURES

 

09.30 Advances in viral infection after Allo-HSCT D. Blaise, Marseille, France 

 

09.30 Advances in viral infection after Allo-HSCT D. Blaise, Marseille, France 

 

10:30
Coffee break & exhibition visit
11:00
  • 11.00 Dose intensity in conditioning of Haplo-HSCT P. Chevallier, Nantes, France
  • 11.30 Advanced lymphoma: best strategy? HSCT? Car T-cells A. Bazarbachi, Beirut, Lebanon
  • 12.00 Advances in immunotherapy for Hodgkin lymphoma: monoclonal antibodies and Haplo-HSCT L. Castagna, Marseille, France
12:30

SESSION 9 – PRACTICAL CONSIDERATIONS

  • 12.30 Cardio toxicities in Haplo-HSCT R. Dulery, Paris, France
  • 12.45 Donor lymphocyte infusion after Haplo-HSCT E. Brissot, Paris, France
  • 13.00 Sickle cell anemia: transplant and gene therapy S. Fürst, Marseille, France
  • 13.15 HSCT in patients older than 70 years S. Harbi, Marseille, France
Top